The global market for Burn and Scald Medicine was valued at US$ 454 million in the year 2024 and is projected to reach a revised size of US$ 601 million by 2031, growing at a CAGR of 3.7% during the forecast period.

Burn and Scald Medicine Market

Burns are a common traumatic disease caused by physical or chemical factors, such as heat, chemistry, electric current and radiation. Small-area burns only cause damage to the skin and (or) mucosal tissue or the corresponding deep tissue. However, larger-area burns can cause functional, metabolic and morphological changes in various systems of the body to varying degrees, causing severe systemic reactions and visceral damage in the injured, and complications such as shock, sepsis and multiple organ failure, with a high mortality rate. The healing and treatment process of burn wounds is complex and takes a long time. After the wound heals, sequelae such as scar contracture and functional impairment may remain. Therefore, burns, especially large-area burns, are the most complex and serious traumatic diseases. In order to treat patients with large-area severe burns, in addition to the need for specialists to have solid basic medical knowledge and experience in burns, other departments such as general surgery, cardiothoracic surgery, urology, orthopedics, anesthesiology and internal medicine need to work together for consultation and treatment to form a team to achieve success. This is the result of collective efforts, cooperation and collaborative work. Burn and scald medicines refer to medicines used to treat skin or tissue damage caused by heat (such as flames, hot water, steam), chemicals, electric current or radiation. The main functions of these medicines are to relieve pain, prevent infection, promote wound healing and reduce scar formation. According to the severity and type of burns, burn and scald medicines can be divided into topical medicines, oral medicines and new therapies. The statistical object of this article is topical medicines for burns and scalds.

The global market for burn and scald medicine is showing a steady growth trend, mainly driven by the improvement of medical standards, the increase in the incidence of burn accidents and the increase in people's health awareness. With the development of industrialization, the acceleration of urbanization and the increase in accidental injuries in the home, the demand for burn and scald treatment drugs is gradually increasing. New drugs are constantly emerging in the field of modern medicine, including growth factor drugs, bioengineered skin substitutes and silver-containing antibacterial drugs. These innovative therapies effectively improve the healing speed of wounds and reduce the risk of infection. At the same time, Chinese herbal medicine and natural plant extracts are gradually gaining market attention as auxiliary treatments, especially in Asia. The North American and European markets are dominated by advanced medical technology and high medical expenditures, while the Asia-Pacific region has become the fastest growing region due to its large population base, increased medical investment and increased public health awareness. The challenges facing the market include high drug research and development costs, complex approval processes, drug side effects and drug resistance. Major players focus on R&D innovation, expanding indications, and improving competitiveness through mergers and acquisitions and strategic cooperation. In the future, with the development of precision medicine and the promotion of personalized treatment plans, the market for burn and scald drugs is expected to maintain steady growth, especially drugs with significant wound healing effects and low side effects, which have greater market potential.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Burn and Scald Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Burn and Scald Medicine.

The Burn and Scald Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Burn and Scald Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Burn and Scald Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Burn and Scald Medicine Market Report

Report Metric	Details
Report Name	Burn and Scald Medicine Market
Accounted market size in year	US$ 454 million
Forecasted market size in 2031	US$ 601 million
CAGR	3.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Ointment Spray Oil Other
Segment by Application	Hospitals and Clinics Retail Pharmacies E-commerce Platforms Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Mebao Pharmaceutical Technology Group, B. Braun, Integra LifeSciences, Jinyao Darentang, Smith & Nephew, Yangtze River Pharmaceutical Group, STADA Thornton & Ross, Kenvue Brands LLC, Changchun Overseas Pharmaceutical Group Co., Ltd., Orkla Health, Guangdong Hengjian Pharmaceutical, Otsuka Pharmaceutical Co., Ltd., Tonghua Maoxiang Pharmaceutical Co., Ltd., Cipla, Tanabe Mitsubishi Pharmaceuticals, Chongqing Xixuan Biotechnology Co., Ltd., Quest Products, LLC, Jianmin Group Yekai Thai Pharmaceutical (Suizhou), Acme United Corp., Dongwha Pharm, China Resources Pharmaceutical Group, Safetec Of America, Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd., North China Pharmaceutical Hebei Huanuo, Xiangxi Hongcheng Pharmaceutical, Hebei Aoxing Group Pharmaceuticals, Jilin Aodong Pharmaceutical Group, Beijing Tongrentang, Henan Quanyu Pharmaceuticals, Chengdu First Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Burn and Scald Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Burn and Scald Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Burn and Scald Medicine Market growing?

Ans: The Burn and Scald Medicine Market witnessing a CAGR of 3.7% during the forecast period 2025-2031.

What is the Burn and Scald Medicine Market size in 2031?

Ans: The Burn and Scald Medicine Market size in 2031 will be US$ 601 million.

Who are the main players in the Burn and Scald Medicine Market report?

Ans: The main players in the Burn and Scald Medicine Market are Mebao Pharmaceutical Technology Group, B. Braun, Integra LifeSciences, Jinyao Darentang, Smith & Nephew, Yangtze River Pharmaceutical Group, STADA Thornton & Ross, Kenvue Brands LLC, Changchun Overseas Pharmaceutical Group Co., Ltd., Orkla Health, Guangdong Hengjian Pharmaceutical, Otsuka Pharmaceutical Co., Ltd., Tonghua Maoxiang Pharmaceutical Co., Ltd., Cipla, Tanabe Mitsubishi Pharmaceuticals, Chongqing Xixuan Biotechnology Co., Ltd., Quest Products, LLC, Jianmin Group Yekai Thai Pharmaceutical (Suizhou), Acme United Corp., Dongwha Pharm, China Resources Pharmaceutical Group, Safetec Of America, Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd., North China Pharmaceutical Hebei Huanuo, Xiangxi Hongcheng Pharmaceutical, Hebei Aoxing Group Pharmaceuticals, Jilin Aodong Pharmaceutical Group, Beijing Tongrentang, Henan Quanyu Pharmaceuticals, Chengdu First Pharmaceuticals

What are the Application segmentation covered in the Burn and Scald Medicine Market report?

Ans: The Applications covered in the Burn and Scald Medicine Market report are Hospitals and Clinics, Retail Pharmacies, E-commerce Platforms, Other

What are the Type segmentation covered in the Burn and Scald Medicine Market report?

Ans: The Types covered in the Burn and Scald Medicine Market report are Ointment, Spray, Oil, Other

1 Burn and Scald Medicine Market Overview

1.1 Product Definition

1.2 Burn and Scald Medicine by Type

1.2.1 Global Burn and Scald Medicine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Ointment

1.2.3 Spray

1.2.4 Oil

1.2.5 Other

1.3 Burn and Scald Medicine by Application

1.3.1 Global Burn and Scald Medicine Market Value by Application (2024 VS 2031)

1.3.2 Hospitals and Clinics

1.3.3 Retail Pharmacies

1.3.4 E-commerce Platforms

1.3.5 Other

1.4 Global Burn and Scald Medicine Market Size Estimates and Forecasts

1.4.1 Global Burn and Scald Medicine Revenue 2020-2031

1.4.2 Global Burn and Scald Medicine Sales 2020-2031

1.4.3 Global Burn and Scald Medicine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Burn and Scald Medicine Market Competition by Manufacturers

2.1 Global Burn and Scald Medicine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Burn and Scald Medicine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Burn and Scald Medicine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Burn and Scald Medicine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Burn and Scald Medicine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Burn and Scald Medicine, Product Type & Application

2.7 Global Key Manufacturers of Burn and Scald Medicine, Date of Enter into This Industry

2.8 Global Burn and Scald Medicine Market Competitive Situation and Trends

2.8.1 Global Burn and Scald Medicine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Burn and Scald Medicine Players Market Share by Revenue

2.8.3 Global Burn and Scald Medicine Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Burn and Scald Medicine Market Scenario by Region

3.1 Global Burn and Scald Medicine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Burn and Scald Medicine Sales by Region: 2020-2031

3.2.1 Global Burn and Scald Medicine Sales by Region: 2020-2025

3.2.2 Global Burn and Scald Medicine Sales by Region: 2026-2031

3.3 Global Burn and Scald Medicine Revenue by Region: 2020-2031

3.3.1 Global Burn and Scald Medicine Revenue by Region: 2020-2025

3.3.2 Global Burn and Scald Medicine Revenue by Region: 2026-2031

3.4 North America Burn and Scald Medicine Market Facts & Figures by Country

3.4.1 North America Burn and Scald Medicine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Burn and Scald Medicine Sales by Country (2020-2031)

3.4.3 North America Burn and Scald Medicine Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Burn and Scald Medicine Market Facts & Figures by Country

3.5.1 Europe Burn and Scald Medicine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Burn and Scald Medicine Sales by Country (2020-2031)

3.5.3 Europe Burn and Scald Medicine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Burn and Scald Medicine Market Facts & Figures by Region

3.6.1 Asia Pacific Burn and Scald Medicine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Burn and Scald Medicine Sales by Region (2020-2031)

3.6.3 Asia Pacific Burn and Scald Medicine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Burn and Scald Medicine Market Facts & Figures by Country

3.7.1 Latin America Burn and Scald Medicine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Burn and Scald Medicine Sales by Country (2020-2031)

3.7.3 Latin America Burn and Scald Medicine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Burn and Scald Medicine Market Facts & Figures by Country

3.8.1 Middle East and Africa Burn and Scald Medicine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Burn and Scald Medicine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Burn and Scald Medicine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Burn and Scald Medicine Sales by Type (2020-2031)

4.1.1 Global Burn and Scald Medicine Sales by Type (2020-2025)

4.1.2 Global Burn and Scald Medicine Sales by Type (2026-2031)

4.1.3 Global Burn and Scald Medicine Sales Market Share by Type (2020-2031)

4.2 Global Burn and Scald Medicine Revenue by Type (2020-2031)

4.2.1 Global Burn and Scald Medicine Revenue by Type (2020-2025)

4.2.2 Global Burn and Scald Medicine Revenue by Type (2026-2031)

4.2.3 Global Burn and Scald Medicine Revenue Market Share by Type (2020-2031)

4.3 Global Burn and Scald Medicine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Burn and Scald Medicine Sales by Application (2020-2031)

5.1.1 Global Burn and Scald Medicine Sales by Application (2020-2025)

5.1.2 Global Burn and Scald Medicine Sales by Application (2026-2031)

5.1.3 Global Burn and Scald Medicine Sales Market Share by Application (2020-2031)

5.2 Global Burn and Scald Medicine Revenue by Application (2020-2031)

5.2.1 Global Burn and Scald Medicine Revenue by Application (2020-2025)

5.2.2 Global Burn and Scald Medicine Revenue by Application (2026-2031)

5.2.3 Global Burn and Scald Medicine Revenue Market Share by Application (2020-2031)

5.3 Global Burn and Scald Medicine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Mebao Pharmaceutical Technology Group

6.1.1 Mebao Pharmaceutical Technology Group Company Information

6.1.2 Mebao Pharmaceutical Technology Group Description and Business Overview

6.1.3 Mebao Pharmaceutical Technology Group Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Mebao Pharmaceutical Technology Group Burn and Scald Medicine Product Portfolio

6.1.5 Mebao Pharmaceutical Technology Group Recent Developments/Updates

6.2 B. Braun

6.2.1 B. Braun Company Information

6.2.2 B. Braun Description and Business Overview

6.2.3 B. Braun Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 B. Braun Burn and Scald Medicine Product Portfolio

6.2.5 B. Braun Recent Developments/Updates

6.3 Integra LifeSciences

6.3.1 Integra LifeSciences Company Information

6.3.2 Integra LifeSciences Description and Business Overview

6.3.3 Integra LifeSciences Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Integra LifeSciences Burn and Scald Medicine Product Portfolio

6.3.5 Integra LifeSciences Recent Developments/Updates

6.4 Jinyao Darentang

6.4.1 Jinyao Darentang Company Information

6.4.2 Jinyao Darentang Description and Business Overview

6.4.3 Jinyao Darentang Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Jinyao Darentang Burn and Scald Medicine Product Portfolio

6.4.5 Jinyao Darentang Recent Developments/Updates

6.5 Smith & Nephew

6.5.1 Smith & Nephew Company Information

6.5.2 Smith & Nephew Description and Business Overview

6.5.3 Smith & Nephew Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Smith & Nephew Burn and Scald Medicine Product Portfolio

6.5.5 Smith & Nephew Recent Developments/Updates

6.6 Yangtze River Pharmaceutical Group

6.6.1 Yangtze River Pharmaceutical Group Company Information

6.6.2 Yangtze River Pharmaceutical Group Description and Business Overview

6.6.3 Yangtze River Pharmaceutical Group Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Yangtze River Pharmaceutical Group Burn and Scald Medicine Product Portfolio

6.6.5 Yangtze River Pharmaceutical Group Recent Developments/Updates

6.7 STADA Thornton & Ross

6.7.1 STADA Thornton & Ross Company Information

6.7.2 STADA Thornton & Ross Description and Business Overview

6.7.3 STADA Thornton & Ross Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 STADA Thornton & Ross Burn and Scald Medicine Product Portfolio

6.7.5 STADA Thornton & Ross Recent Developments/Updates

6.8 Kenvue Brands LLC

6.8.1 Kenvue Brands LLC Company Information

6.8.2 Kenvue Brands LLC Description and Business Overview

6.8.3 Kenvue Brands LLC Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Kenvue Brands LLC Burn and Scald Medicine Product Portfolio

6.8.5 Kenvue Brands LLC Recent Developments/Updates

6.9 Changchun Overseas Pharmaceutical Group Co., Ltd.

6.9.1 Changchun Overseas Pharmaceutical Group Co., Ltd. Company Information

6.9.2 Changchun Overseas Pharmaceutical Group Co., Ltd. Description and Business Overview

6.9.3 Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Product Portfolio

6.9.5 Changchun Overseas Pharmaceutical Group Co., Ltd. Recent Developments/Updates

6.10 Orkla Health

6.10.1 Orkla Health Company Information

6.10.2 Orkla Health Description and Business Overview

6.10.3 Orkla Health Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Orkla Health Burn and Scald Medicine Product Portfolio

6.10.5 Orkla Health Recent Developments/Updates

6.11 Guangdong Hengjian Pharmaceutical

6.11.1 Guangdong Hengjian Pharmaceutical Company Information

6.11.2 Guangdong Hengjian Pharmaceutical Description and Business Overview

6.11.3 Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Product Portfolio

6.11.5 Guangdong Hengjian Pharmaceutical Recent Developments/Updates

6.12 Otsuka Pharmaceutical Co., Ltd.

6.12.1 Otsuka Pharmaceutical Co., Ltd. Company Information

6.12.2 Otsuka Pharmaceutical Co., Ltd. Description and Business Overview

6.12.3 Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Portfolio

6.12.5 Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates

6.13 Tonghua Maoxiang Pharmaceutical Co., Ltd.

6.13.1 Tonghua Maoxiang Pharmaceutical Co., Ltd. Company Information

6.13.2 Tonghua Maoxiang Pharmaceutical Co., Ltd. Description and Business Overview

6.13.3 Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Portfolio

6.13.5 Tonghua Maoxiang Pharmaceutical Co., Ltd. Recent Developments/Updates

6.14 Cipla

6.14.1 Cipla Company Information

6.14.2 Cipla Description and Business Overview

6.14.3 Cipla Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Cipla Burn and Scald Medicine Product Portfolio

6.14.5 Cipla Recent Developments/Updates

6.15 Tanabe Mitsubishi Pharmaceuticals

6.15.1 Tanabe Mitsubishi Pharmaceuticals Company Information

6.15.2 Tanabe Mitsubishi Pharmaceuticals Description and Business Overview

6.15.3 Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Product Portfolio

6.15.5 Tanabe Mitsubishi Pharmaceuticals Recent Developments/Updates

6.16 Chongqing Xixuan Biotechnology Co., Ltd.

6.16.1 Chongqing Xixuan Biotechnology Co., Ltd. Company Information

6.16.2 Chongqing Xixuan Biotechnology Co., Ltd. Description and Business Overview

6.16.3 Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Product Portfolio

6.16.5 Chongqing Xixuan Biotechnology Co., Ltd. Recent Developments/Updates

6.17 Quest Products, LLC

6.17.1 Quest Products, LLC Company Information

6.17.2 Quest Products, LLC Description and Business Overview

6.17.3 Quest Products, LLC Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Quest Products, LLC Burn and Scald Medicine Product Portfolio

6.17.5 Quest Products, LLC Recent Developments/Updates

6.18 Jianmin Group Yekai Thai Pharmaceutical (Suizhou)

6.18.1 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Company Information

6.18.2 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Description and Business Overview

6.18.3 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.18.4 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Product Portfolio

6.18.5 Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Recent Developments/Updates

6.19 Acme United Corp.

6.19.1 Acme United Corp. Company Information

6.19.2 Acme United Corp. Description and Business Overview

6.19.3 Acme United Corp. Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.19.4 Acme United Corp. Burn and Scald Medicine Product Portfolio

6.19.5 Acme United Corp. Recent Developments/Updates

6.20 Dongwha Pharm

6.20.1 Dongwha Pharm Company Information

6.20.2 Dongwha Pharm Description and Business Overview

6.20.3 Dongwha Pharm Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.20.4 Dongwha Pharm Burn and Scald Medicine Product Portfolio

6.20.5 Dongwha Pharm Recent Developments/Updates

6.21 China Resources Pharmaceutical Group

6.21.1 China Resources Pharmaceutical Group Company Information

6.21.2 China Resources Pharmaceutical Group Description and Business Overview

6.21.3 China Resources Pharmaceutical Group Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.21.4 China Resources Pharmaceutical Group Burn and Scald Medicine Product Portfolio

6.21.5 China Resources Pharmaceutical Group Recent Developments/Updates

6.22 Safetec Of America

6.22.1 Safetec Of America Company Information

6.22.2 Safetec Of America Description and Business Overview

6.22.3 Safetec Of America Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.22.4 Safetec Of America Burn and Scald Medicine Product Portfolio

6.22.5 Safetec Of America Recent Developments/Updates

6.23 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd.

6.23.1 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Company Information

6.23.2 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Description and Business Overview

6.23.3 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.23.4 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product Portfolio

6.23.5 Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Recent Developments/Updates

6.24 North China Pharmaceutical Hebei Huanuo

6.24.1 North China Pharmaceutical Hebei Huanuo Company Information

6.24.2 North China Pharmaceutical Hebei Huanuo Description and Business Overview

6.24.3 North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.24.4 North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Product Portfolio

6.24.5 North China Pharmaceutical Hebei Huanuo Recent Developments/Updates

6.25 Xiangxi Hongcheng Pharmaceutical

6.25.1 Xiangxi Hongcheng Pharmaceutical Company Information

6.25.2 Xiangxi Hongcheng Pharmaceutical Description and Business Overview

6.25.3 Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.25.4 Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Product Portfolio

6.25.5 Xiangxi Hongcheng Pharmaceutical Recent Developments/Updates

6.26 Hebei Aoxing Group Pharmaceuticals

6.26.1 Hebei Aoxing Group Pharmaceuticals Company Information

6.26.2 Hebei Aoxing Group Pharmaceuticals Description and Business Overview

6.26.3 Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.26.4 Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Product Portfolio

6.26.5 Hebei Aoxing Group Pharmaceuticals Recent Developments/Updates

6.27 Jilin Aodong Pharmaceutical Group

6.27.1 Jilin Aodong Pharmaceutical Group Company Information

6.27.2 Jilin Aodong Pharmaceutical Group Description and Business Overview

6.27.3 Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.27.4 Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Product Portfolio

6.27.5 Jilin Aodong Pharmaceutical Group Recent Developments/Updates

6.28 Beijing Tongrentang

6.28.1 Beijing Tongrentang Company Information

6.28.2 Beijing Tongrentang Description and Business Overview

6.28.3 Beijing Tongrentang Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.28.4 Beijing Tongrentang Burn and Scald Medicine Product Portfolio

6.28.5 Beijing Tongrentang Recent Developments/Updates

6.29 Henan Quanyu Pharmaceuticals

6.29.1 Henan Quanyu Pharmaceuticals Company Information

6.29.2 Henan Quanyu Pharmaceuticals Description and Business Overview

6.29.3 Henan Quanyu Pharmaceuticals Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.29.4 Henan Quanyu Pharmaceuticals Burn and Scald Medicine Product Portfolio

6.29.5 Henan Quanyu Pharmaceuticals Recent Developments/Updates

6.30 Chengdu First Pharmaceuticals

6.30.1 Chengdu First Pharmaceuticals Company Information

6.30.2 Chengdu First Pharmaceuticals Description and Business Overview

6.30.3 Chengdu First Pharmaceuticals Burn and Scald Medicine Sales, Revenue and Gross Margin (2020-2025)

6.30.4 Chengdu First Pharmaceuticals Burn and Scald Medicine Product Portfolio

6.30.5 Chengdu First Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Burn and Scald Medicine Industry Chain Analysis

7.2 Burn and Scald Medicine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Burn and Scald Medicine Production Mode & Process Analysis

7.4 Burn and Scald Medicine Sales and Marketing

7.4.1 Burn and Scald Medicine Sales Channels

7.4.2 Burn and Scald Medicine Distributors

7.5 Burn and Scald Medicine Customer Analysis

8 Burn and Scald Medicine Market Dynamics

8.1 Burn and Scald Medicine Industry Trends

8.2 Burn and Scald Medicine Market Drivers

8.3 Burn and Scald Medicine Market Challenges

8.4 Burn and Scald Medicine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Smith & Nephew

Integra LifeSciences

B. Braun

Yangtze River Pharmaceutical Group

STADA Thornton & Ross

Kenvue Brands LLC

Changchun Overseas Pharmaceutical Group Co., Ltd.

Orkla Health

Guangdong Hengjian Pharmaceutical

Otsuka Pharmaceutical Co Ltd

Tonghua Maoxiang Pharmaceutical Co., Ltd.

China Resources Pharmaceutical Group

Safetec of America

Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd.

Jilin Aodong Pharmaceutical Group

Beijing Tongrentang

Mebao Pharmaceutical Technology Group

Jinyao Darentang

Tanabe Mitsubishi Pharmaceuticals

Chongqing Xixuan Biotechnology Co., Ltd.

Jianmin Group Yekai Thai Pharmaceutical (Suizhou)

North China Pharmaceutical Hebei Huanuo

Xiangxi Hongcheng Pharmaceutical

Hebei Aoxing Group Pharmaceuticals

Henan Quanyu Pharmaceuticals

Chengdu First Pharmaceuticals

List of Tables

Table 1. Global Burn and Scald Medicine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Burn and Scald Medicine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Burn and Scald Medicine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Burn and Scald Medicine Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Burn and Scald Medicine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Burn and Scald Medicine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Burn and Scald Medicine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Burn and Scald Medicine Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Burn and Scald Medicine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Burn and Scald Medicine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Burn and Scald Medicine, Product Type & Application

Table 12. Global Key Manufacturers of Burn and Scald Medicine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Burn and Scald Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Burn and Scald Medicine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Burn and Scald Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Burn and Scald Medicine Sales by Region (2020-2025) & (K Units)

Table 18. Global Burn and Scald Medicine Sales Market Share by Region (2020-2025)

Table 19. Global Burn and Scald Medicine Sales by Region (2026-2031) & (K Units)

Table 20. Global Burn and Scald Medicine Sales Market Share by Region (2026-2031)

Table 21. Global Burn and Scald Medicine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Burn and Scald Medicine Revenue Market Share by Region (2020-2025)

Table 23. Global Burn and Scald Medicine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Burn and Scald Medicine Revenue Market Share by Region (2026-2031)

Table 25. North America Burn and Scald Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Burn and Scald Medicine Sales by Country (2020-2025) & (K Units)

Table 27. North America Burn and Scald Medicine Sales by Country (2026-2031) & (K Units)

Table 28. North America Burn and Scald Medicine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Burn and Scald Medicine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Burn and Scald Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Burn and Scald Medicine Sales by Country (2020-2025) & (K Units)

Table 32. Europe Burn and Scald Medicine Sales by Country (2026-2031) & (K Units)

Table 33. Europe Burn and Scald Medicine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Burn and Scald Medicine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Burn and Scald Medicine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Burn and Scald Medicine Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Burn and Scald Medicine Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Burn and Scald Medicine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Burn and Scald Medicine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Burn and Scald Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Burn and Scald Medicine Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Burn and Scald Medicine Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Burn and Scald Medicine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Burn and Scald Medicine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Burn and Scald Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Burn and Scald Medicine Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Burn and Scald Medicine Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Burn and Scald Medicine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Burn and Scald Medicine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Burn and Scald Medicine Sales (K Units) by Type (2020-2025)

Table 51. Global Burn and Scald Medicine Sales (K Units) by Type (2026-2031)

Table 52. Global Burn and Scald Medicine Sales Market Share by Type (2020-2025)

Table 53. Global Burn and Scald Medicine Sales Market Share by Type (2026-2031)

Table 54. Global Burn and Scald Medicine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Burn and Scald Medicine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Burn and Scald Medicine Revenue Market Share by Type (2020-2025)

Table 57. Global Burn and Scald Medicine Revenue Market Share by Type (2026-2031)

Table 58. Global Burn and Scald Medicine Price (US$/Unit) by Type (2020-2025)

Table 59. Global Burn and Scald Medicine Price (US$/Unit) by Type (2026-2031)

Table 60. Global Burn and Scald Medicine Sales (K Units) by Application (2020-2025)

Table 61. Global Burn and Scald Medicine Sales (K Units) by Application (2026-2031)

Table 62. Global Burn and Scald Medicine Sales Market Share by Application (2020-2025)

Table 63. Global Burn and Scald Medicine Sales Market Share by Application (2026-2031)

Table 64. Global Burn and Scald Medicine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Burn and Scald Medicine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Burn and Scald Medicine Revenue Market Share by Application (2020-2025)

Table 67. Global Burn and Scald Medicine Revenue Market Share by Application (2026-2031)

Table 68. Global Burn and Scald Medicine Price (US$/Unit) by Application (2020-2025)

Table 69. Global Burn and Scald Medicine Price (US$/Unit) by Application (2026-2031)

Table 70. Mebao Pharmaceutical Technology Group Company Information

Table 71. Mebao Pharmaceutical Technology Group Description and Business Overview

Table 72. Mebao Pharmaceutical Technology Group Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Mebao Pharmaceutical Technology Group Burn and Scald Medicine Product

Table 74. Mebao Pharmaceutical Technology Group Recent Developments/Updates

Table 75. B. Braun Company Information

Table 76. B. Braun Description and Business Overview

Table 77. B. Braun Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. B. Braun Burn and Scald Medicine Product

Table 79. B. Braun Recent Developments/Updates

Table 80. Integra LifeSciences Company Information

Table 81. Integra LifeSciences Description and Business Overview

Table 82. Integra LifeSciences Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Integra LifeSciences Burn and Scald Medicine Product

Table 84. Integra LifeSciences Recent Developments/Updates

Table 85. Jinyao Darentang Company Information

Table 86. Jinyao Darentang Description and Business Overview

Table 87. Jinyao Darentang Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Jinyao Darentang Burn and Scald Medicine Product

Table 89. Jinyao Darentang Recent Developments/Updates

Table 90. Smith & Nephew Company Information

Table 91. Smith & Nephew Description and Business Overview

Table 92. Smith & Nephew Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Smith & Nephew Burn and Scald Medicine Product

Table 94. Smith & Nephew Recent Developments/Updates

Table 95. Yangtze River Pharmaceutical Group Company Information

Table 96. Yangtze River Pharmaceutical Group Description and Business Overview

Table 97. Yangtze River Pharmaceutical Group Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Yangtze River Pharmaceutical Group Burn and Scald Medicine Product

Table 99. Yangtze River Pharmaceutical Group Recent Developments/Updates

Table 100. STADA Thornton & Ross Company Information

Table 101. STADA Thornton & Ross Description and Business Overview

Table 102. STADA Thornton & Ross Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. STADA Thornton & Ross Burn and Scald Medicine Product

Table 104. STADA Thornton & Ross Recent Developments/Updates

Table 105. Kenvue Brands LLC Company Information

Table 106. Kenvue Brands LLC Description and Business Overview

Table 107. Kenvue Brands LLC Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Kenvue Brands LLC Burn and Scald Medicine Product

Table 109. Kenvue Brands LLC Recent Developments/Updates

Table 110. Changchun Overseas Pharmaceutical Group Co., Ltd. Company Information

Table 111. Changchun Overseas Pharmaceutical Group Co., Ltd. Description and Business Overview

Table 112. Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Changchun Overseas Pharmaceutical Group Co., Ltd. Burn and Scald Medicine Product

Table 114. Changchun Overseas Pharmaceutical Group Co., Ltd. Recent Developments/Updates

Table 115. Orkla Health Company Information

Table 116. Orkla Health Description and Business Overview

Table 117. Orkla Health Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Orkla Health Burn and Scald Medicine Product

Table 119. Orkla Health Recent Developments/Updates

Table 120. Guangdong Hengjian Pharmaceutical Company Information

Table 121. Guangdong Hengjian Pharmaceutical Description and Business Overview

Table 122. Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Guangdong Hengjian Pharmaceutical Burn and Scald Medicine Product

Table 124. Guangdong Hengjian Pharmaceutical Recent Developments/Updates

Table 125. Otsuka Pharmaceutical Co., Ltd. Company Information

Table 126. Otsuka Pharmaceutical Co., Ltd. Description and Business Overview

Table 127. Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Otsuka Pharmaceutical Co., Ltd. Burn and Scald Medicine Product

Table 129. Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 130. Tonghua Maoxiang Pharmaceutical Co., Ltd. Company Information

Table 131. Tonghua Maoxiang Pharmaceutical Co., Ltd. Description and Business Overview

Table 132. Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Tonghua Maoxiang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product

Table 134. Tonghua Maoxiang Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 135. Cipla Company Information

Table 136. Cipla Description and Business Overview

Table 137. Cipla Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Cipla Burn and Scald Medicine Product

Table 139. Cipla Recent Developments/Updates

Table 140. Tanabe Mitsubishi Pharmaceuticals Company Information

Table 141. Tanabe Mitsubishi Pharmaceuticals Description and Business Overview

Table 142. Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. Tanabe Mitsubishi Pharmaceuticals Burn and Scald Medicine Product

Table 144. Tanabe Mitsubishi Pharmaceuticals Recent Developments/Updates

Table 145. Chongqing Xixuan Biotechnology Co., Ltd. Company Information

Table 146. Chongqing Xixuan Biotechnology Co., Ltd. Description and Business Overview

Table 147. Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 148. Chongqing Xixuan Biotechnology Co., Ltd. Burn and Scald Medicine Product

Table 149. Chongqing Xixuan Biotechnology Co., Ltd. Recent Developments/Updates

Table 150. Quest Products, LLC Company Information

Table 151. Quest Products, LLC Description and Business Overview

Table 152. Quest Products, LLC Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 153. Quest Products, LLC Burn and Scald Medicine Product

Table 154. Quest Products, LLC Recent Developments/Updates

Table 155. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Company Information

Table 156. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Description and Business Overview

Table 157. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 158. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Burn and Scald Medicine Product

Table 159. Jianmin Group Yekai Thai Pharmaceutical (Suizhou) Recent Developments/Updates

Table 160. Acme United Corp. Company Information

Table 161. Acme United Corp. Description and Business Overview

Table 162. Acme United Corp. Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 163. Acme United Corp. Burn and Scald Medicine Product

Table 164. Acme United Corp. Recent Developments/Updates

Table 165. Dongwha Pharm Company Information

Table 166. Dongwha Pharm Description and Business Overview

Table 167. Dongwha Pharm Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 168. Dongwha Pharm Burn and Scald Medicine Product

Table 169. Dongwha Pharm Recent Developments/Updates

Table 170. China Resources Pharmaceutical Group Company Information

Table 171. China Resources Pharmaceutical Group Description and Business Overview

Table 172. China Resources Pharmaceutical Group Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 173. China Resources Pharmaceutical Group Burn and Scald Medicine Product

Table 174. China Resources Pharmaceutical Group Recent Developments/Updates

Table 175. Safetec Of America Company Information

Table 176. Safetec Of America Description and Business Overview

Table 177. Safetec Of America Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 178. Safetec Of America Burn and Scald Medicine Product

Table 179. Safetec Of America Recent Developments/Updates

Table 180. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Company Information

Table 181. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Description and Business Overview

Table 182. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 183. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Burn and Scald Medicine Product

Table 184. Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd. Recent Developments/Updates

Table 185. North China Pharmaceutical Hebei Huanuo Company Information

Table 186. North China Pharmaceutical Hebei Huanuo Description and Business Overview

Table 187. North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 188. North China Pharmaceutical Hebei Huanuo Burn and Scald Medicine Product

Table 189. North China Pharmaceutical Hebei Huanuo Recent Developments/Updates

Table 190. Xiangxi Hongcheng Pharmaceutical Company Information

Table 191. Xiangxi Hongcheng Pharmaceutical Description and Business Overview

Table 192. Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 193. Xiangxi Hongcheng Pharmaceutical Burn and Scald Medicine Product

Table 194. Xiangxi Hongcheng Pharmaceutical Recent Developments/Updates

Table 195. Hebei Aoxing Group Pharmaceuticals Company Information

Table 196. Hebei Aoxing Group Pharmaceuticals Description and Business Overview

Table 197. Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 198. Hebei Aoxing Group Pharmaceuticals Burn and Scald Medicine Product

Table 199. Hebei Aoxing Group Pharmaceuticals Recent Developments/Updates

Table 200. Jilin Aodong Pharmaceutical Group Company Information

Table 201. Jilin Aodong Pharmaceutical Group Description and Business Overview

Table 202. Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 203. Jilin Aodong Pharmaceutical Group Burn and Scald Medicine Product

Table 204. Jilin Aodong Pharmaceutical Group Recent Developments/Updates

Table 205. Beijing Tongrentang Company Information

Table 206. Beijing Tongrentang Description and Business Overview

Table 207. Beijing Tongrentang Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 208. Beijing Tongrentang Burn and Scald Medicine Product

Table 209. Beijing Tongrentang Recent Developments/Updates

Table 210. Henan Quanyu Pharmaceuticals Company Information

Table 211. Henan Quanyu Pharmaceuticals Description and Business Overview

Table 212. Henan Quanyu Pharmaceuticals Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 213. Henan Quanyu Pharmaceuticals Burn and Scald Medicine Product

Table 214. Henan Quanyu Pharmaceuticals Recent Developments/Updates

Table 215. Chengdu First Pharmaceuticals Company Information

Table 216. Chengdu First Pharmaceuticals Description and Business Overview

Table 217. Chengdu First Pharmaceuticals Burn and Scald Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 218. Chengdu First Pharmaceuticals Burn and Scald Medicine Product

Table 219. Chengdu First Pharmaceuticals Recent Developments/Updates

Table 220. Key Raw Materials Lists

Table 221. Raw Materials Key Suppliers Lists

Table 222. Burn and Scald Medicine Distributors List

Table 223. Burn and Scald Medicine Customers List

Table 224. Burn and Scald Medicine Market Trends

Table 225. Burn and Scald Medicine Market Drivers

Table 226. Burn and Scald Medicine Market Challenges

Table 227. Burn and Scald Medicine Market Restraints

Table 228. Research Programs/Design for This Report

Table 229. Key Data Information from Secondary Sources

Table 230. Key Data Information from Primary Sources

Table 231. Authors List of This Report

List of Figures

Figure 1. Product Picture of Burn and Scald Medicine

Figure 2. Global Burn and Scald Medicine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Burn and Scald Medicine Market Share by Type: 2024 & 2031

Figure 4. Ointment Product Picture

Figure 5. Spray Product Picture

Figure 6. Oil Product Picture

Figure 7. Other Product Picture

Figure 8. Global Burn and Scald Medicine Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Burn and Scald Medicine Market Share by Application: 2024 & 2031

Figure 10. Hospitals and Clinics

Figure 11. Retail Pharmacies

Figure 12. E-commerce Platforms

Figure 13. Other

Figure 14. Global Burn and Scald Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Burn and Scald Medicine Market Size (2020-2031) & (US$ Million)

Figure 16. Global Burn and Scald Medicine Sales (2020-2031) & (K Units)

Figure 17. Global Burn and Scald Medicine Average Price (US$/Unit) & (2020-2031)

Figure 18. Burn and Scald Medicine Report Years Considered

Figure 19. Burn and Scald Medicine Sales Share by Manufacturers in 2024

Figure 20. Global Burn and Scald Medicine Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Burn and Scald Medicine Players: Market Share by Revenue in Burn and Scald Medicine in 2024

Figure 22. Burn and Scald Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Burn and Scald Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Burn and Scald Medicine Sales Market Share by Country (2020-2031)

Figure 25. North America Burn and Scald Medicine Revenue Market Share by Country (2020-2031)

Figure 26. United States Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Burn and Scald Medicine Sales Market Share by Country (2020-2031)

Figure 29. Europe Burn and Scald Medicine Revenue Market Share by Country (2020-2031)

Figure 30. Germany Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Burn and Scald Medicine Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Burn and Scald Medicine Revenue Market Share by Region (2020-2031)

Figure 37. China Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. China Taiwan Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Southeast Asia Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Burn and Scald Medicine Sales Market Share by Country (2020-2031)

Figure 45. Latin America Burn and Scald Medicine Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Colombia Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Burn and Scald Medicine Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Burn and Scald Medicine Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Burn and Scald Medicine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Burn and Scald Medicine by Type (2020-2031)

Figure 56. Global Revenue Market Share of Burn and Scald Medicine by Type (2020-2031)

Figure 57. Global Burn and Scald Medicine Price (US$/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Burn and Scald Medicine by Application (2020-2031)

Figure 59. Global Revenue Market Share of Burn and Scald Medicine by Application (2020-2031)

Figure 60. Global Burn and Scald Medicine Price (US$/Unit) by Application (2020-2031)

Figure 61. Burn and Scald Medicine Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Burn Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Burn Care Products and Accessories Market Research Report 2024

Global Skin Burn Treatment Market Research Report 2025

Global Burn Care Market Research Report 2024

Burn Dressing Market

Medical Remedies Solutions for Skin Burns Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Burn Treatment Bathtub Market Research Report 2024

Global Burns Treatment Market Research Report 2025

Global Burns Dressing Market Research Report 2024

Global Scar Treatment Drugs Market Insights Forecast to 2030

Global Post Surgical Scar Treatment Market Research Report 2025

Global Burns Kits Market Research Report 2024

Topical Scar Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Face Mask Burn Dressing Market Research Report 2024

Global Skin and Wound Care Market Insights Forecast to 2030

Global Radiation Dermatitis Medicines Market Research Report 2025

Global Heat Therapy Units Market Insights Forecast to 2030

Global Burn Injury Treatment Market Insights Forecast to 2030

Burn Care Supplies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions